# A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery

> **NCT01143740** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 20 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** RO5045337

## Key facts

- **NCT ID:** NCT01143740
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01143740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01143740, "A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT01143740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*